Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2009
11/18/2009EP2117586A1 Treatment or prophylaxis of asthma
11/18/2009EP2117553A2 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track
11/18/2009EP2117541A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117537A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009EP2117529A2 Methods for treating diseases of altered ige regulation
11/18/2009EP1529049B1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/18/2009EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009CN101583377A Treatment of fibrosis
11/18/2009CN101583373A Therapeutic agent for interstitial pneumonia
11/18/2009CN101579529A Oligonucleotide compositions and method for treating disease including inflammatory conditions
11/18/2009CN101579523A Egg yolk immunoglobulins oral and throat spraying agent and preparation method thereof
11/18/2009CN101579502A Wormwood strip containing natural aromatic plants
11/18/2009CN101579489A Medicine for treating pharyngitis and preparation method thereof
11/18/2009CN101579486A Pill for clearing away heat for children
11/18/2009CN101579474A Veterinary drug granules for preventing and treating avian infectious laryngotracheitis and preparation method thereof
11/18/2009CN101579473A Traditional Chinese medicine for treating infant bronchitis
11/18/2009CN101579472A Traditional Chinese medicine for treating infantile pneumonia
11/18/2009CN101579457A Traditional Chinese medicine for treating infant cough caused by external factor
11/18/2009CN101579449A Method for preparing oleum viticis negundo dripping pills
11/18/2009CN101579428A Zhuhuang Chuihou preparation and preparation technology thereof
11/18/2009CN101579425A Oral pharmaceutical preparation
11/18/2009CN101579404A Traditional Chinese medicine granules for treating infectious laryngotracheitis of chicken, and preparation method thereof
11/18/2009CN101579391A Traditional Chinese medicine effervescent tablet for preventing and curing cold
11/18/2009CN101579384A Rhinitis healing ointment and preparation method and using method thereof
11/18/2009CN101579359A Compound cod-liver oil nasal drops and preparation method
11/18/2009CN101579342A Desloratadine-contained patulin composition
11/18/2009CN101579315A Immunoliposome based on endostatin gene, preparation method and application thereof
11/18/2009CN101579186A Pharmaceutical rhinitis pillow for external use and treating wind-heat rhinitis
11/18/2009CN101579185A Pharmaceutical rhinitis pillow for external use and treating wind-cold rhinitis
11/18/2009CN101579114A Health protection tea for treating hoarseness
11/18/2009CN100561229C A cytocapacity test
11/18/2009CN100560102C Traditional Chinese medicine for treating lung heat cough and high fever
11/18/2009CN100560084C Method and preparations having effect against allergic symptoms
11/18/2009CN100560065C Asarone fatty emulsion and its preparing method
11/17/2009US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009US7618994 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis
11/17/2009US7618979 Prostaglandin receptor antagonists; allergic rhinitis, nasal congestion and asthma; [5-[(4-chlorophenyl)thio]-4-(methylsulfonyl)-6,7,8,9-tetrahydropyrido[3,2-b]indolizin-6-yl]acetic acid
11/17/2009US7618962 Pyrazolyl substituted xanthines
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618649 For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2411368C Therapeutic combinations of fatty acids
11/17/2009CA2398992C Therapeutic or preventive agent for pulmonary insufficiency containing a diaminotrifluoromethylpyridine derivative
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2374158C Indole derivatives
11/17/2009CA2341429C Treatment of mucus hypersecretion
11/17/2009CA2336822C Method of treatment and pharmaceutical composition
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2318536C Method of and compositions for immunization with the pseudomonas v antigen
11/17/2009CA2304973C Stabilized preparations for use in nebulizers
11/12/2009WO2009137611A2 Treatment of pulmonary fungal infection with voriconazole via inhalation
11/12/2009WO2009137334A2 Method for treating neurodegenerative dysfunction
11/12/2009WO2009137087A2 A method for preventing or alleviating the noxious effects resulting from toxicant exposure
11/12/2009WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases
11/12/2009WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135599A1 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
11/12/2009WO2009135579A1 Polymorph of 8-hydroxy-5- [(1r)-1-hydroxy-2- [[(1r) -2-(4-methoxyphenyl) -1-methylethyl] amino] ethyl] -2(1h)-quinolinone monohydrochloride
11/12/2009WO2009135577A1 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2- (4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)- quinolinone monohydrochloride
11/12/2009WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033767A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009US20090281169 Compositions and Their Uses Directed to IL-4R Alpha
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281156 Enhancing photostabilization of oxymetazoline
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090280129 High concentration antibody and protein formulations
11/12/2009US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009US20090280115 Dihydropteridinones in the Treatment of Respiratory Diseases
11/12/2009US20090280105 Novel Fungal Enzymes
11/12/2009US20090280099 Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
11/12/2009US20090280087 Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer
11/12/2009US20090280068 Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009US20090280067 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009CA2723688A1 Method for treating neurodegenerative dysfunction
11/12/2009CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
11/12/2009CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/11/2009EP2116537A1 Polymorph of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride
11/11/2009EP2116536A1 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)- quinolinone monohydrochloride
11/11/2009EP2116264A1 Preparation for transnasal application
11/11/2009EP2116245A2 EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
11/11/2009EP2114970A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/11/2009EP2114889A1 Method of preparing montelukast and intermediates used therein
11/11/2009EP2114888A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
11/11/2009EP2114870A1 Synthetic ion channels
11/11/2009EP2114460A2 Methods and compositions for the disruption of biofilms
11/11/2009EP2114417A1 New use of nitrites and nitrates and compositions containing these
1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 878